XK and pantothenate kinase-associated neurodegeneration: As has subsequently been demonstrated with molecular studies of Hardie’s cases, in addition to patients with ChAc, the series contained an atypical female carrier with a McLeod gene (XK) mutation and compatible symptoms, and at least three cases with PKAN [8, 9].